Acurx Announces Presentation of a Scientific Poster at the Premier International C. difficile Symposium (ICDS) Demonstrating Superior In Vitro Kill Kinetics of Ibezapolstat vs. Vancomycin and Fidaxomicin (Standards of Care) in Clostridioides difficile and Vancomycin-Resistant Enterococcus Co-Cultures

ConferenceibezapolstatvancomycinfidaxomicinPositive

AI Analysis

Summary

Acurx announced presentation of a scientific poster at the International C. difficile Symposium demonstrating superior in vitro kill kinetics of ibezapolstat compared to vancomycin and fidaxomicin against C. difficile and vancomycin-resistant Enterococcus co-cultures.

Importance:3/10

Sentiment:

0.60

in vitro studyC. difficilekill kineticsconference presentationrecurrent CDI

Related Companies

$ISCO $MOLN

Read the original article

Published by PR Newswire Biotech on September 14, 2026 12:01 PM

Read Original